TGA Approval

EYLEA aflibercept (rch) 40 mg/mL solution for intravitreal injection pre-filled syringe (180860)

ARTG ID

180860

ARTG Name

EYLEA aflibercept (rch) 40 mg/mL solution for intravitreal injection pre-filled syringe

Sponsor

Bayer Australia Ltd

ARTG Date

March 7, 2012

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

BAYER AUSTRALIA LTD

https://medical-cdn.nocode.com/drug_tga/f700f5468cf1363cd5c250a8a12d5132.pdf

https://medical-cdn.nocode.com/drug_tga/f1f0b987fec443eb38e4d66462a681f8.pdf

Ingredient Name

Aflibercept

Empowering clinical research with data-driven insights and AI-powered tools.

EYLEA aflibercept (rch) 40 mg/mL solution for intravitreal injection pre-filled syringe (180860) - TGA 批准文号 | MedPath